Skip to main content

Peer Review reports

From: Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma

Original Submission
8 Jan 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Jan 2021 Reviewed Reviewer Report
28 Jan 2021 Reviewed Reviewer Report - Kazuhiko Kurozumi
3 Feb 2021 Reviewed Reviewer Report - Fei-yi-fan Wang
23 Feb 2021 Author responded Author comments - Wenqi Song
Resubmission - Version 3
23 Feb 2021 Submitted Manuscript version 3
19 Mar 2021 Author responded Author comments - Wenqi Song
Resubmission - Version 4
19 Mar 2021 Submitted Manuscript version 4
23 Mar 2021 Author responded Author comments - Wenqi Song
Resubmission - Version 5
23 Mar 2021 Submitted Manuscript version 5
6 Apr 2021 Reviewed Reviewer Report - Fei-yi-fan Wang
18 Apr 2021 Reviewed Reviewer Report - Kazuhiko Kurozumi
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
22 Apr 2021 Editorially accepted
18 May 2021 Article published 10.1186/s12865-021-00422-y

You can find further information about peer review here.

Back to article page